Benjamin Kasenda

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. pmc Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)
    Benjamin Kasenda
    Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland
    BMC Med Res Methodol 12:131. 2012
  2. doi request reprint 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma
    Benjamin Kasenda
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    J Nucl Med 54:184-91. 2013
  3. doi request reprint [Lung cancer screening - an overview about chances and risks]
    Benjamin Kasenda
    Institut für Klinische Epidemiologie und Biostatistik, Universitatsspital Basel
    Ther Umsch 70:237-43; discussion 244. 2013
  4. doi request reprint Prevalence, characteristics, and publication of discontinued randomized trials
    Benjamin Kasenda
    Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital of Basel, Basel, Switzerland
    JAMA 311:1045-51. 2014
  5. pmc Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
    Elisabeth Schorb
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    Haematologica 98:765-70. 2013

Detail Information

Publications5

  1. pmc Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)
    Benjamin Kasenda
    Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland
    BMC Med Res Methodol 12:131. 2012
    ..Currently, little is known regarding the frequency and characteristics of discontinued RCTs...
  2. doi request reprint 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma
    Benjamin Kasenda
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    J Nucl Med 54:184-91. 2013
    ..Primary central nervous system (CNS) lymphoma is an aggressive non-Hodgkin lymphoma with poor prognosis. We evaluated pretreatment (18)F-FDG PET as a prognostic marker in primary CNS lymphoma...
  3. doi request reprint [Lung cancer screening - an overview about chances and risks]
    Benjamin Kasenda
    Institut für Klinische Epidemiologie und Biostatistik, Universitatsspital Basel
    Ther Umsch 70:237-43; discussion 244. 2013
    ..Whether LDCT screening is associated with an acceptable incremental cost-effectiveness ratio still warrants further investigation...
  4. doi request reprint Prevalence, characteristics, and publication of discontinued randomized trials
    Benjamin Kasenda
    Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital of Basel, Basel, Switzerland
    JAMA 311:1045-51. 2014
    ..The discontinuation of randomized clinical trials (RCTs) raises ethical concerns and often wastes scarce research resources. The epidemiology of discontinued RCTs, however, remains unclear...
  5. pmc Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
    Elisabeth Schorb
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    Haematologica 98:765-70. 2013
    ..Superiority compared to standard chemotherapy still warrants further investigation...